Join the club for FREE to access the whole archive and other member benefits.

Exciting Therapy To Treat Age Related Blindness Moving To The Clinic


Key points from article :

Ichor Therapeutics is a biotechnology company focused on developing drugs for age-related diseases.

LYSOCLEAR for age-related macular degeneration and Stargardt’s macular degeneration going into Phase I clinical trials.

Age-related macular degeneration (AMD) is the leading cause of vision loss among people over the age of 50.

With time, different by-products are formed that accumulate in the lysosomes of RPE cells.

LYSOCLEAR is an enzyme product that can enter the lysosomes of RPE cells and destroy toxic A2E accumulations.

We are now seeing the first SENS therapies proposed back in 2000s moving into clinical trials.

Mentioned in this article:

Click on resource name for more details.

Aubrey de Grey

President and Chief Science Officer at Longevity Escape Velocity (LEV) Foundation

Ichor Therapeutics

Company that develops clinical products in the field of regenerative medicine

UNITY Biotechnology

Biotechnology company devoted to research of restoring human health

Topics mentioned on this page: